Raymond James & Associates Chimerix Inc Transaction History
Raymond James & Associates
- $161 Billion
- Q3 2024
A detailed history of Raymond James & Associates transactions in Chimerix Inc stock. As of the latest transaction made, Raymond James & Associates holds 13,200 shares of CMRX stock, worth $12,144. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,200
Previous 23,200
43.1%
Holding current value
$12,144
Previous $20,000
40.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding CMRX
# of Institutions
81Shares Held
36.8MCall Options Held
72.2KPut Options Held
169K-
Ra Capital Management, L.P. Boston, MA8.8MShares$8.1 Million0.12% of portfolio
-
Monaco Asset Management Sam4.38MShares$4.03 Million0.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.35MShares$4 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY2.22MShares$2.05 Million0.03% of portfolio
-
Acadian Asset Management LLC Boston, MA2.17MShares$2 Million0.01% of portfolio
About CHIMERIX INC
- Ticker CMRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,622,896
- Market Cap $80.6M
- Description
- Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...